Paul Newton et al | 13 Dec 2011 | Malaria Journal
Criminals are producing diverse harmful anti-malarial counterfeits with important public health consequences. The presence of artesunate monotherapy, substandard and/or degraded and counterfeit medicines containing sub-therapeutic amounts of unexpected anti-malarials will engender drug resistance.
Tanya Shewchuk et al | 31 Oct 2011 | Malaria Journal
ACTwatch is a unique multi-country research project that threads together anti-malarial supply and consumer behaviour to provide an evidence base to policy makers that can help determine where interventions may positively impact access to and use of quality-assured ACT and RDTs. Because of its ability to detect change over time, it is well suited to monitor the effects of policy or intervention developments in a country.
Mary Hamel et al. | 31 Oct 2011 | American Journal of Tropical Medicine and Hygiene
We report and explore changes in child mortality in a rural area of Kenya during 2003-2009, when major public health interventions were scaled-up. Mortality ratios and rates were calculated by using the Kenya Medical Research Institute/Centers for Disease Control and Prevention Demographic Surveillance System.
Mthokozisi Sibanda et al | 18 Oct 2011 | Malaria Journal
Bioassay experiments indicated that incorporating insecticides into a conventional paint binder or adsorbing them onto phosphogypsum can provide for extended effective life spans that compare favourably with DDT's performance under accelerated ageing conditions.
Kija R Ng'habi et al | 05 Oct 2011 | Malaria Journal
Genetic diversity is a key factor that enables adaptation and persistence of natural populations towards environmental conditions.
Alassane F Ouattara et al | 04 Oct 2011 | Malaria Journal
To improve effectiveness of malaria control interventions, it is essential to deepen the knowledge of contextual factors that govern people's practice for preventive and curative measures.
None | 24 Sep 2011 | The Lancet
In The Lancet today, we report the presentation of this year's Lasker-DeBakey Clinical Medical Research Award to Tu Youyou, a Chinese pharmacologist, for discovering the antimalarial drug artemisinin in the 1970s.
Linda V Kalilani-Phiri et al | 22 Sep 2011 | Malaria Journal
Malaria still remains a life-threatening disease worldwide causing between 190 and 311 million cases of malaria in 2008.
Arnaud Le Menach et al | 15 Sep 2011 | Scientific Reports
The prevalence of Plasmodium falciparum malaria in Zanzibar has reached historic lows. Improving control requires quantifying malaria importation rates, identifying high-risk travelers, and assessing onwards transmission.
Roger Bate & Richard Tren | 08 Sep 2011 | American Enterprise Institute
By trying to do too much, the disease-fighting Global Fund has run into problems. It is spending public funds in a way that is perverting the market for malaria drugs and could do more harm than good.